What is Peripheral Neuropathy and how do I know if I have it??
Peripheral Neuropathy is a medical condition in which the nerves that travel from your brain and spinal cord function improperly. Most people will complain that they are experiencing burning, tingling, numbness, and or shooting pains to their lower extremities. Most of the time the symptoms of neuropathy will begin in the feet. Numbness in the toes or in the ball of the foot seems to be where most people feel these sensations first.
What causes Neuropathy?
There are over 100 causes of peripeheral neuropathy. Some of the more common ones include diabetes, thiamine deficiency, alcoholism, trauma, exposure to toxins, autoimmune diseases, and infections. Sometimes no cause can be determined.
Can you treat Neuropathy?
Yes, a treatment plan can be formed based on the cause of your neuropathy. If you are Thiamine deficient (easily determined with a blood test), you can begin to take supplements of thiamine and the symptoms should eradicate.
Neuremedy is another option for treating neuropathy.
What is Neuremedy?
Neuremedy is a medical supplement that helps treat dysfunctional nerves allowing them to impulse correctly. It contains benofotiamine and has been determined to be safe and successful in treatment of neuropathy. Neuremedy is able to help alleviate the symptoms of neuropathy by delivering a highly bio active form of the micro-nutrient thiamine to the nerve cells.
Is Neuremedy safe?
The active ingredient in Neuremedy is benfotiamine. It has been used since the early 1960's to successfully treat neuropathy. It has been proven to be safe and effective. It does not have any known significant adverse effects and can be safely taken with medicines and supplements.
How Quickly does Neuremedy work?
Most people begin to notice a reduction of symptoms within the first two months of taking the supplement. Unfortunately neuremedy does not work for everyone. Ask your doctor if Neuremedy is right for you.
Wednesday, February 17, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment